Prostate Adenocarcinoma
Showing NaN - NaN of 15
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Durvalumab
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023
Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Best Practice, Dietary Intervention, Exercise
Recruiting
- Localized Prostate Carcinoma
- Prostate Adenocarcinoma
- Best Practice
- +4 more
-
Seattle, Washington
- +1 more
Jan 9, 2023
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Laboratory Biomarker Analysis
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 19, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)
Recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 23, 2022
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
Biochemically Recurrent Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +6 more
- Computed Tomography
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 7, 2022
Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)
Terminated
- Prostate Adenocarcinoma
- Apalutamide
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 28, 2021
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC V7, Stage IIA Prostate Cancer AJCC v7 Trial in Seattle (Behavioral Dietary
Terminated
- Prostate Adenocarcinoma
- +2 more
- Behavioral Dietary Intervention
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 8, 2021
Metabolic and Hormone Action on Plaque Formation in Brain and
Terminated
- Prostate Adenocarcinoma
- Evaluation
- Quality-of-Life Assessment
-
Seattle, WashingtonFred Hutch/University of Washington
Dec 8, 2020
Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma, Prostate Adenocarcinoma Trial in Portland, Seattle
Terminated
- Hormone-Resistant Prostate Cancer
- +3 more
- Biopsy of Prostate
- +3 more
-
Portland, Oregon
- +2 more
Sep 19, 2019
Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Seattle (drug, radiation, other)
Completed
- Prostate Adenocarcinoma
- +4 more
- Degarelix
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2018
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Canada, United States (drug,
Completed
- Prostate Adenocarcinoma
- +2 more
- Bicalutamide
- +5 more
-
Fairbanks, Alaska
- +169 more
Feb 23, 2018
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)
Completed
- Prostate Adenocarcinoma
- +4 more
- Bicalutamide
- +5 more
-
Los Angeles, California
- +14 more
Sep 18, 2017